- Home
- GERN vs RWT Comparison
GERN vs RWT Comparison
Compare GERN & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- RWT
- Stock Information
- Founded
- GERN 1990
- RWT 1994
- Country
- GERN United States
- RWT United States
- Employees
- GERN N/A
- RWT N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- RWT Real Estate Investment Trusts
- Sector
- GERN Health Care
- RWT Real Estate
- Exchange
- GERN Nasdaq
- RWT Nasdaq
- Market Cap
- GERN 853.5M
- RWT 756.1M
- IPO Year
- GERN 1996
- RWT 1995
- Fundamental
- Price
- GERN $1.51
- RWT $5.63
- Analyst Decision
- GERN Buy
- RWT Buy
- Analyst Count
- GERN 7
- RWT 11
- Target Price
- GERN $4.17
- RWT $7.59
- AVG Volume (30 Days)
- GERN 10.9M
- RWT 703.1K
- Earning Date
- GERN 08-07-2025
- RWT 07-31-2025
- Dividend Yield
- GERN N/A
- RWT 12.77%
- EPS Growth
- GERN N/A
- RWT 105.35
- EPS
- GERN N/A
- RWT 0.21
- Revenue
- GERN $116,293,000.00
- RWT $241,796,000.00
- Revenue This Year
- GERN $160.12
- RWT N/A
- Revenue Next Year
- GERN $55.01
- RWT $3.43
- P/E Ratio
- GERN N/A
- RWT $26.74
- Revenue Growth
- GERN 22264.04
- RWT 29.65
- 52 Week Low
- GERN $1.17
- RWT $4.68
- 52 Week High
- GERN $5.06
- RWT $8.15
- Technical
- Relative Strength Index (RSI)
- GERN 51.36
- RWT 47.62
- Support Level
- GERN $1.42
- RWT $5.67
- Resistance Level
- GERN $1.58
- RWT $5.91
- Average True Range (ATR)
- GERN 0.10
- RWT 0.12
- MACD
- GERN -0.01
- RWT 0.01
- Stochastic Oscillator
- GERN 40.00
- RWT 49.11
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.